Brazil suspends clinical trials of Bharat Biotech's Covaxin

“The Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studies of the Covaxin vaccine in Brazil,”Anvisa, the Brazilian health regulator said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eSN4Jz
via IFTTT